IL1B and colitis: However, in TNBS-induced ileitis and DSS-induced colitis, GLP-2 treatment downregulated expression of inflammatory cytokines, including IFN-γ, TNF-α, and IL-1β, while the anti-inflammatory cytokine IL-10 was increased (93).